Back to Search Start Over

Biflorin inhibits the proliferation of gastric cancer cells by decreasing MYC expression.

Authors :
Barbosa-Jobim GS
Costa-Lira É
Ralph ACL
Gregório L
Lemos TLG
Burbano RR
Calcagno DQ
Smith MAC
Montenegro RC
Vasconcellos MC
Source :
Toxicology in vitro : an international journal published in association with BIBRA [Toxicol In Vitro] 2020 Mar; Vol. 63, pp. 104735. Date of Electronic Publication: 2019 Nov 18.
Publication Year :
2020

Abstract

Gastric cancer is the third leading cause of cancer-related death worldwide. To evaluate the anticancer potential and molecular mechanism of biflorin, a prenyl-ortho-naphthoquinone obtained from Capraria biflora L. roots, we used ACP02, a gastric cancer cell line established from a primary diffuse gastric adenocarcinoma. In this study, biflorin was shown to be a potent cytotoxic agent against ACP02 by Alamar Blue and Trypan Blue assays. Morphological analysis indicated cell death with features of necrosis. Furthermore, a decrease in colony formation, migration and invasion of ACP02 cells was observed after treatment with biflorin (1.0, 2.5 and 5.0 μM). Regarding the underlying molecular mechanism of biflorin in ACP02 cells, we observed a decrease in MYC expression and telomere length using FISH. Our findings suggest a novel molecular target of biflorin in ACP02 cells, which may be a significant therapeutic approach for gastric cancer management.<br /> (Copyright © 2019 Elsevier Ltd. All rights reserved.)

Details

Language :
English
ISSN :
1879-3177
Volume :
63
Database :
MEDLINE
Journal :
Toxicology in vitro : an international journal published in association with BIBRA
Publication Type :
Academic Journal
Accession number :
31751609
Full Text :
https://doi.org/10.1016/j.tiv.2019.104735